1. Home
  2. Browse
  3. HRA000679
HRA000679
   HRA000679.xlsx
Title:
Longitudinal peripheral blood transcriptional analysis reveals molecular signatures of disease progression in COVID-19 patients
Release date:
2021-02-25
Description:
Coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with some patients can develop severe illness or even death. Disease severity has been associated with increased levels of pro-inflammatory cytokines and lymphopenia. To elucidate the atlas of peripheral immune response and pathways that might lead to immunopathology during COVID-19 disease course, we performed a peripheral blood RNA sequencing analysis of samples collected from the symptom onset to full recovery.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA004237
Study type:
Disease Study
Disease name:
COVID-19
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC000378
DAC name:
GIBH
Contact person:
Yan Qihong
Email:
yan_qihong@gibh.ac.cn
Description:
Qihong Yan is the co-first author of this study. Cantact me if you are interested in the data.
Individuals & samples
Files
Request Data
Submitter:   Chen Ling / chen_ling@gibh.ac.cn
Organization:   The First Affiliated Hospital of Guangzhou Medical University
Submission date:   2021-01-11
Requests:   6